Profound Medical Corp. Announces Third Quarter 2015 Financial Results

-Activities Across All Areas Ramping Up-

Mississauga, Ontario, CANADA


-Activities Across All Areas Ramping Up-
TORONTO, Nov. 4, 2015 (GLOBE NEWSWIRE) -- Profound Medical Corp. ("Profound" or "Company") (TSXV:PRN), a medical device company developing and commercializing a unique, minimally invasive treatment to ablate the prostate gland in prostate cancer patients, today reported financial results for the three and nine months ended September 30, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars.